BD Exports $48.2B +8.7% YoY RMG $40.6B +7.2% BGMEA Members 4,275 Top Destination USA $9.1B Jute $1.2B Leather $950M +12.4% Pharma $180M +18.2% Japan EPA Active Feb 2026 EU EBA Duty-Free HS Codes 7,498 BD Exports $48.2B +8.7% YoY RMG $40.6B +7.2% BGMEA Members 4,275 Top Destination USA $9.1B Jute $1.2B Leather $950M +12.4% Pharma $180M +18.2% Japan EPA Active Feb 2026 EU EBA Duty-Free HS Codes 7,498
English | USD $

Medical Device Manufacturing in Bangladesh: A New Investment Opportunity for Global Healthcare Companies

Bangladesh's medical device sector is emerging as a high-growth investment opportunity — strong pharma base, 170M domestic market, DGDA regulatory framework, and growing export ambitions to ME, SE Asia, and Africa.

S
System Administrator
July 21, 2026 13 min read
Medical Device Manufacturing in Bangladesh: A New Investment Opportunity for Global Healthcare Companies

Bangladesh's medical device manufacturing sector is at an inflection point. Long overshadowed by the country's pharmaceutical industry (which meets 97% of domestic medicinal demand and exports to 150+ countries), medical device manufacturing is now emerging as a distinct high-growth investment opportunity — driven by rising domestic demand, regulatory maturation, and growing export ambitions to the Middle East, Southeast Asia, and Africa.

For global healthcare companies, medical device OEMs, and healthcare investors evaluating manufacturing locations beyond China and India, Bangladesh offers a compelling combination: a large and growing domestic market (170M+ population), a regulatory framework aligned with international standards (DGDA), a strong pharmaceutical manufacturing base to leverage for combination products, and competitive labor costs. This guide covers the sector's current state, investment opportunities, regulatory framework, and how to connect with verified Bangladeshi medical and pharmaceutical manufacturers.

1. Medical Device Sector Growth — The 2026 Snapshot

Bangladesh's medical device market is estimated at $650-750 million in 2025, growing at 12-15% annually. The market is currently import-dependent (over 85% of devices are imported), but domestic manufacturing is expanding rapidly in several segments:

SegmentDomestic ProductionImport ShareGrowth Rate
Basic disposables (syringes, gloves)High (80%+)Low8% CAGR
Hospital furniture and bedsMedium (50%)Medium10% CAGR
Diagnostic equipmentLow (15%)High (85%)15% CAGR
Implantable devicesVery low (5%)Very high (95%)18% CAGR
Surgical instrumentsMedium (40%)Medium12% CAGR
Pharma combination productsMedium-High (60%)Medium20% CAGR

2. Domestic Demand Drivers — 170M Patient Market

Bangladesh's domestic medical device demand is driven by structural demographic and healthcare trends:

  • 170M+ population — among the world's 10 most populous countries
  • Rising middle class — 40+ million middle-income households with discretionary healthcare spending
  • Aging population — 7% of population is 60+ years (growing 3% annually)
  • Non-communicable disease burden — diabetes, cardiovascular disease, cancer rates rising
  • Healthcare infrastructure expansion — 600+ private hospitals, 18 medical colleges added in last 5 years
  • Universal Health Coverage push — government investing in community clinics and district hospitals
  • Medical tourism potential — Bangladesh positioned to serve as medical tourism destination for neighboring countries

3. Import Substitution Opportunity

With 85% of medical devices currently imported, the import substitution opportunity alone is substantial. Major import categories include:

  • Diagnostic imaging (MRI, CT, X-ray) — $120M annual imports, dominated by Siemens, GE, Philips
  • Patient monitoring systems — $45M annual imports
  • Surgical and operating room equipment — $60M annual imports
  • Dental equipment — $25M annual imports
  • Orthopedic implants — $35M annual imports
  • Cardiovascular stents and pacemakers — $40M annual imports

For manufacturers willing to set up local assembly or full production, the domestic market alone can justify the investment — particularly for mid-tier devices where Bangladesh's labor cost advantage is most relevant.

4. Export Opportunities — ME, SE Asia, and Africa

Beyond the domestic market, Bangladeshi medical device manufacturers have credible export opportunities in three regions:

4.1 Middle East (Halal-compliant medical products)

GCC countries (Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain) import $4+ billion in medical devices annually. Bangladesh can position as a halal-certified medical product manufacturer for the Muslim world — particularly for pharmaceutical combinations, personal care, and dietary supplements with medical claims.

4.2 Southeast Asia (cost-competitive generics)

Indonesia, Vietnam, Philippines, and Myanmar represent growing markets for affordable medical devices. Bangladesh's manufacturing cost structure is competitive with Vietnam and superior to Indonesia for labor-intensive assembly.

4.3 Africa (essential medical supplies)

African countries import $8+ billion annually in medical devices, with significant unmet demand for basic disposables, hospital equipment, and affordable diagnostics. Bangladesh's experience in supplying affordable pharmaceuticals to Africa (via Square, Beximco, Incepta) provides distribution channel leverage.

5. Regulatory Framework — DGDA and International Standards

Bangladesh's medical device regulatory framework is administered by the Directorate General of Drug Administration (DGDA), under the Ministry of Health and Family Welfare. Key regulatory milestones:

  • Medical Device Act 2022 — comprehensive framework for medical device registration, manufacturing licensing, and post-market surveillance
  • MDR (Medical Device Rules) 2023 — operational rules implementing the Act
  • Classification system — Class A (low risk), B (moderate), C (high), D (highest) — aligned with International Medical Device Regulators Forum (IMDRF)
  • ISO 13485 adoption — most established manufacturers are ISO 13485:2016 certified
  • CE marking — several manufacturers have CE-marked products for EU export
  • US FDA registration — a growing number of pharma facilities are FDA-approved
🏛️ Verify Medical Device Regulations on Official Portals
• DGDA (Medical Device Regulation): dgda.gov.bd
• Ministry of Health and Family Welfare: mohfw.gov.bd
• BIDA (Investment Approval): bida.gov.bd

6. Government Incentives for Medical Device Manufacturing

Medical device manufacturing qualifies for several government incentives:

  • Tax holiday — 5-10 year tax exemption (sector-specific, location-dependent)
  • Customs duty exemption — duty-free import of capital machinery and raw materials for export-oriented medical device manufacturing
  • Cash incentive — 4-10% cash incentive on pharmaceutical and medical device export earnings
  • SEZ priority — medical device parks planned within Bangabandhu Sheikh Mujib Shilpa Nagar and other SEZs
  • Skills development — government co-financing for biomedical engineering training programs
  • R&D incentive — 30% tax rebate on R&D expenditure for medical device companies

7. Industry Ecosystem and Existing Players

While dedicated medical device manufacturing is nascent, Bangladesh has a strong pharmaceutical manufacturing ecosystem to build upon:

  • Square Pharmaceuticals — largest pharma company in Bangladesh, $400M+ revenue, FDA-approved facilities, expanding into medical devices
  • Beximco Pharmaceuticals — major exporter to regulated markets, R&D capabilities
  • Incepta Pharmaceuticals — broad product portfolio, cGMP-compliant facilities
  • Eskayef Pharmaceuticals — US FDA-approved insulin manufacturer
  • ACI Healthcare — diversified healthcare company with medical device distribution
  • Local medical device specialists — emerging companies in syringes, surgical instruments, and hospital furniture

The Pharmaceuticals & Medical category on BangladeshExport.com lists verified Bangladeshi pharma and medical device suppliers.

8. Investment Segments — Where the Opportunities Are

For investors evaluating medical device manufacturing in Bangladesh, the most attractive segments are:

8.1 Hospital Furniture and Beds (Lower Risk, Faster Setup)

Manufacturing hospital beds, examination tables, IV stands, patient trolleys. Low regulatory complexity, leverages Bangladesh's existing light engineering capability.

8.2 Basic Disposables (Established Market)

Syringes, IV sets, surgical gloves, wound dressings, urine bags. Mature domestic demand, established distribution channels.

8.3 Diagnostic Reagents (Medium Risk, Higher Value)

In-vitro diagnostic reagents, rapid test kits, blood collection tubes. Leverages Bangladesh's pharmaceutical chemistry capability.

8.4 Surgical Instruments (Specialty Manufacturing)

Stainless steel surgical instruments, dental instruments, ophthalmic instruments. Niche market with high value-addition.

8.5 Combination Products (Highest Value, Leverages Pharma Base)

Drug-eluting stents, transdermal patches, prefilled syringes, inhalers. Combines Bangladesh's pharma strength with device manufacturing.

9. Find Verified Medical and Pharma Manufacturers

BangladeshExport.com provides direct access to verified Bangladeshi pharmaceutical and medical device manufacturers:

🔍 Verified Pharma & Medical Device Databases

Pharma & Medical Category — verified suppliersBrowse →
All Verified Suppliers — 18,000+ across categoriesBrowse →
Invest in Bangladesh — comprehensive guideView →
Post RFQ — request quotes from verified suppliersPost RFQ →

10. Frequently Asked Questions

❓ What is the regulatory authority for medical devices in Bangladesh?
The Directorate General of Drug Administration (DGDA), under the Ministry of Health and Family Welfare. The Medical Device Act 2022 and Medical Device Rules 2023 provide the comprehensive regulatory framework. DGDA classifies devices into Class A, B, C, and D (aligned with IMDRF) — with progressively stricter requirements for higher-risk classes.
❓ Can a foreign company set up 100% foreign-owned medical device manufacturing in Bangladesh?
Yes. 100% foreign equity is permitted in medical device manufacturing. The company must obtain: (1) DGDA manufacturing license, (2) BIDA investment registration, (3) RJSC company registration, (4) environmental clearance. With BIDA One-Stop Service, the entire process typically takes 4-6 months.
❓ Are Bangladeshi medical devices accepted in international markets?
Several Bangladeshi pharmaceutical facilities are US FDA-approved and EU GMP-certified. For medical devices specifically, a growing number of manufacturers have CE-marked products for EU export. Square Pharmaceuticals, Beximco, and Eskayef have established track records in regulated markets. The DGDA is working toward MRA (Mutual Recognition Agreement) with ASEAN and GCC regulators.
❓ What is the size of Bangladesh's medical device market?
Approximately $650-750 million in 2025, growing at 12-15% annually. Domestic production accounts for 15-20% of the market, with imports dominating diagnostic equipment, implantables, and high-end surgical instruments. The government aims to increase domestic production share to 40% by 2030.
❓ What tax incentives are available for medical device manufacturers?
Medical device manufacturing qualifies for: (1) 5-10 year tax holiday depending on location and segment, (2) customs duty exemption on capital machinery and raw materials for export-oriented production, (3) 4-10% cash incentive on export earnings, (4) 30% tax rebate on R&D expenditure, (5) repatriation of profits for foreign investors.
❓ How can I find a Bangladeshi partner for medical device manufacturing?
Browse the Pharma & Medical category on BangladeshExport.com to find verified manufacturers with DGDA licenses, ISO 13485 certifications, and export track records. Post an RFQ to receive quotes from multiple suppliers and evaluate partnership opportunities.

💊 Explore Medical Device Manufacturing in Bangladesh

Connect with verified Bangladeshi pharmaceutical and medical device manufacturers. Access DGDA regulatory guidance, BIDA investment facilitation, and ISO 13485-certified supplier directories.

Register as Buyer — Free →

Last updated: July 2026. Industry data sourced from Directorate General of Drug Administration (DGDA), Bangladesh Investment Development Authority (BIDA), Ministry of Health and Family Welfare, and industry analyst reports. For the latest medical device regulations, please verify on dgda.gov.bd.

S
System Administrator
Bangladesh export industry insights and analysis

Related Articles

Share: